JournalsHub
.online
Find My Journal
VB

Vesna Bjelic‐Radisic

Witten/Herdecke University DE

ORCID iD 0000-0002-3749-4775
280
Publications
6,882
Citations
39
H-Index
90
i10-Index
2.48
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer OA
Michael Gnant, Brigitte Mlineritsch, Walter Schippinger, G. Luschin-Ebengreuth, Sabine Pöstlberger +16 more
New England Journal of Medicine 2009
1,020
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
Michael Gnant, Georg Pfeiler, Peter Dubsky, Michael Hubalek, Richard Greil +21 more
The Lancet 2015
556
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
Michael Gnant, Brigitte Mlineritsch, G. Luschin-Ebengreuth, Franz Kainberger, H. Kässmann +15 more
The Lancet Oncology 2008
397
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12 OA
Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger, G. Luschin-Ebengreuth, Michael Knauer +20 more
Annals of Oncology 2014
304
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
Michael Gnant, Georg Pfeiler, Günther Steger, Daniel Egle, Richard Greil +14 more
The Lancet Oncology 2019
233

Publications

279 total

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer PDF

Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, Fedro A. Peccatori, Hatem A. Azim et al. - New England Journal of Medicine, 2023
Cited by 209 OpenAlex

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer PDF

Michael Gnant, Florian Fitzal, Gabriel Rinnerthaler, Guenther G. Steger, Sigrun Greil‐Ressler et al. - New England Journal of Medicine, 2021
Cited by 158 OpenAlex

An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45 PDF

Vesna Bjelic‐Radisic, Fátima Cardoso, David Cameron, Étienne Brain, Karin Kuljanić et al. - Annals of Oncology, 2020
Cited by 141 OpenAlex

Plasma proteins facilitates placental transfer of polystyrene particles PDF

Michael Gruber, Birgit Hirschmugl, Natascha Berger, Magdalena Holter, Snježana Radulović et al. - Journal of Nanobiotechnology, 2020
Cited by 100 OpenAlex

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

Michael Gnant, Georg Pfeiler, Günther Steger, Daniel Egle, Richard Greil et al. - The Lancet Oncology, 2019
Cited by 233 OpenAlex

Impact of Breast Surgery in Primary Metastasized Breast Cancer

Florian Fitzal, Vesna Bjelic‐Radisic, Michael Knauer, Günther Steger, Michael Hubalek et al. - Annals of Surgery, 2018
Cited by 204 OpenAlex

Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy PDF

William P. Weber, Martin Haug, Christian Kurzeder, Vesna Bjelic‐Radisic, Rupert Koller et al. - Breast Cancer Research and Treatment, 2018
Cited by 123 OpenAlex

First international consensus conference on standardization of oncoplastic breast conserving surgery

William P. Weber, Savas D. Soysal, Mahmoud El‐Tamer, Virgilio Sacchini, Michael Knauer et al. - Breast Cancer Research and Treatment, 2017
Cited by 118 OpenAlex

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial

Michael Gnant, Georg Pfeiler, Peter Dubsky, Michael Hubalek, Richard Greil et al. - The Lancet, 2015
Cited by 556 OpenAlex

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12 PDF

Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger, G. Luschin-Ebengreuth, Michael Knauer et al. - Annals of Oncology, 2014
Cited by 304 OpenAlex

Research Topics

Breast Cancer Treatment Studies (81) Pelvic floor disorders treatments (37) Breast Implant and Reconstruction (36) Advanced Breast Cancer Therapies (31) Cancer survivorship and care (27)

Frequent Co-Authors

MI
Michael Gnant
9 joint publications
FL
Florian Fitzal
9 joint publications
RI
Richard Greil
8 joint publications
PE
Peter Dubsky
7 joint publications
BR
Brigitte Mlineritsch
6 joint publications
R.
R. Jakesz
6 joint publications

Affiliations

European Organisation for Research and Treatment of Cancer
NL 2018 - 2018
University of Sydney
AU 2017 - 2017
University of Vienna
AT 2011 - 2011
Amgen (United States)
US 2016 - 2016
Innsbruck Medical University
AT 2016 - 2016

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now